TG Therapeutics Inc logo

TG Therapeutics Inc

FRA:NKB2 (USA)   Ordinary Shares
€ 15.43 (+3.46%) May 31
74.14
P/B:
15.74
Market Cap:
€ 2.33B ($ 2.52B)
Enterprise V:
€ 2.24B ($ 2.43B)
Volume:
13.00
Avg Vol (2M):
103.00
Also Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (FRA:NKB2) Operating Data Charts